Simvastatin Brand Change Update
As advised via Pharmac Tender announcement 28 April 2017 there is to be a change in the listing and future sole supply.
New listing from 1 November 2017
Simvastatin-Mylan Tab 10 mg 90 Pharmacode 2520087 Schedule price $0.95
Simvastatin-Mylan Tab 20 mg 90 Pharmacode 2520095 Schedule price $1.52
Simvastatin-Mylan Tab 40 mg 90 Pharmacode 2520109 Schedule price $2.63
Simvastatin-Mylan Tab 80 mg 90 Pharmacode 2520117 Schedule price $6.00
Simva-Arrow Tab 10 mg 90 Pharmacode 2316668 Schedule price $0.95
Simva-Arrow Tab 20 mg 90 Pharmacode 2316676 Schedule price $1.61
Simva-Arrow Tab 40 mg 90 Pharmacode 2316684 Schedule price $2.83
Simva-Arrow Tab 80 mg 90 Pharmacode 2316692 Schedule price $7.91
Reference pricing has been deferred until further notice (was to be 1 January 2018)
STAT Dispensing will formally be removed and dispensing in one month lots is recommended.
We recommend you continue to purchase the incumbent and we will change automatically as existing stocks are depleted.
Click here to read the PHARMAC Dispatch from 21 December 2017
Benefit of staying with incumbent
In association with Actavis pricing was reduced significantly from 2 October 2017. Allocations have been removed.
Click here to review the Simvastatin $$ Analysis
These additional margin gains may appear minimal but on volume they are significant.
Click here to access the Simvastatin Mylan Tablet Description & Dimensions. Mylan stock has now been received at Mylan and will be distributed to wholesalers as soon as practical.
Once again we need your support to ensure stock in the supply chain moves through to effectively ensure no losses are incurred.
Together we can make this a seamless and painless transition.
We thank you in anticipation of your ongoing support.